Publication | Closed Access

Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial

Treatment And PreventionAntiretroviral-naive AdultsClinical TrialsAntiviral Drug DevelopmentAntiviral Therapy96-Week ResultsAntiviral DrugHivMedicine